Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous mesenchymal stem cells for pulmonary arterial hypertension due to systemic sclerosis
NL-OMON41219Phase 2Withdrawn
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow derived mesenchymal stromal cells in pulmonary arterial hypertension (PAH), systemic sclerosis (SSc), sponsored by Leiden University Medical Center. Planned start Dec 2014; status: withdrawn.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
pulmonary arterial hypertension (PAH)systemic sclerosis (SSc)
Beyond the preview
Go deeper on NL-OMON41219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41219.